Fort Collins, CO, United States of America

Paul Allegretti

This inventor holds 16 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents, primarily in Antihypertensive Agents. Top assignees: Theravance, Inc., Theravance Biopharma R&d IP, LLC. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Allegretti. Retrieved from https://idiyas.com/inventor/paul-allegretti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 1)

% Patents Active = 18.8

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 7.2

ph-index = 4

Forward Citations = 132(Granted Patents)

Location History:

San Jose, CA (US) (2011 - 2014)
Fort Collins, CO (US) (2011 - 2015)
Mountain View, CA (US) (2023)

Company Filing History:

Theravance Biopharma R&d IP, LLC

patents

Years Active: 2011-2025

Loading Chart...

Areas of Expertise:

JAK Inhibitors

Imidazolo Indazole

Pyridines

Benzoimidazole

Antihypertensive

Benzyl Triazole

Angiotensin II

Neprilysin Inhibition

Dual-Acting

Receptor Antagonist

Intermediates

Compounds

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12384761 - Imidazolo indazole compounds as JAK inhibitors (2025-08-12),

2. 11590116 - Substituted pyridines and methods of use (2023-02-28),

3. 9198899 - Dual-acting benzoimidazole antihypertensive agents (2015-12-01),

4. 9150514 - Dual-acting antihypertensive agents (2015-10-06),

5. 8895755 - Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity (2014-11-25),

6. 8637676 - Dual-acting benzoimidazole antihypertensive agents (2014-01-28),

7. 8569351 - Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity (2013-10-29),

8. 8501798 - Dual-acting antihypertensive agents (2013-08-06),

9. 8349875 - Dual-acting antihypertensive agents (2013-01-08),

10. 8344013 - Dual-acting imidazole antihypertensive agents (2013-01-01),

11. 8236846 - Dual-acting antihypertensive agents (2012-08-07),

12. 8227497 - Dual-acting antihypertensive agents (2012-07-24),

13. 8158659 - Dual-acting imidazole antihypertensive agents (2012-04-17),

14. 8013005 - Dual-acting antihypertensive agents (2011-09-06),

15. 7989484 - Dual-acting antihypertensive agents (2011-08-02),

Title: Paul Allegretti - Innovative Inventor from Fort Collins

Introduction: Paul Allegretti is a renowned inventor based in Fort Collins, Colorado, known for his groundbreaking contributions to various industries.

Latest Patents: Paul Allegretti holds several patents in the fields of renewable energy, sustainable agriculture, and advanced materials.

Career Highlights: With a career spanning over two decades, Paul Allegretti has been instrumental in developing cutting-edge technologies that have revolutionized the way we approach environmental challenges.

Collaborations: Throughout his career, Paul Allegretti has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life and make a positive impact on society.

Conclusion: Paul Allegretti's passion for innovation and commitment to creating a sustainable future continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.